M.P.H, Harvard School of Public Health, 1996.
M.D., Stanford University of Medicine, 1990.
B.S., University of Washington, 1984.
Dr. Lee’s expertise and research interests focus on survivorship issues, quality-of-life and the impact of chronic graft-versus-host-disease.
Dr. Lee is a hematologist who provides hematopoietic cell transplants using bone marrow, peripheral blood and cord blood for patients with blood diseases such as leukemia and myelodysplastic syndrome.
NIH/NCI: Immune mediated disorders after allogeneic hematopoietic cell transplantation, Principal Investigator, 9/25/09 – 8/31/14.
NIH/NCI: Improving outcomes assessment in chronic GVHD, Principal Investigator, 3/1/13 – 2/28/18.
NIH/NCI: Internet studies to enhance long term survivorship after hematologic malignancy (PI: Syrjala), Co-investigator, 9/9/11 – 7/31/16.
NIH/NCI: Leadership of core long term follow-up program (PI: Appelbaum), Co-Investigator, 9/25/12 – 6/30/17.
NCI/NHLBI: BMT CTN 0902, Phase 3 randomized trial testing whether exercise or stress management improves quality of life in transplant patients (PI: Appelbaum), National Co-Principal Investigator, 7/1/12 – 6/30/17.
Phase 2 trial of low-dose interleukin-2 for steroid refractory chronic GVHD (PI: Koreth), Site Principal Investigator, 4/1/13 – 3/31/15.